Enable-supported Serosurvey in the News

Dr. David Seftel, Enable Biosciences’ CEO and Dr. Peter Robinson, Enable Biosciences’ COO were quoted in an article from the Santa Cruz Sentinel and Mercury News describing CalScope, the California Department of Public Health (CDPH) state-wide serosurvey. Enable’s Clinical Reference Lab is the provider of antibody tests for the program.

Read the article here:

https://www.santacruzsentinel.com/2022/01/02/california-engaged-in-groundbreaking-covid-antibody-study/

Previous
Previous

Enable Biosciences Clinical Reference Lab Accredited by the College of American Pathologists (CAP)

Next
Next

Enable-supported CalScope Serosurvey Program Issues First Preprint